The Center for Acute Care Nephrology offers comprehensive therapy options when treating acute kidney injury needs. Armed with the most advanced therapies, the CACN adapts treatments to accommodate a patient’s conditions. Through our collaborative work with partners at Cincinnati Children’s and other institutions, the CACN team members are able to provide the following services:
Acute Renal Replacement Therapies: Acute renal replacement therapies can be initiated for acute kidney injury, fluid overload and/or sepsis. The collaborative decision to start renal replacement therapy is based on many factors and helps determine which therapy can be started.
- Acute Hemodialysis: This therapy supports kidney function by maintaining fluid and electrolyte balance in the patient. This therapy offers the highest amount of dialysis in the shortest amount of time. Acute hemodialysis occurs daily or every other day with a three to four hour treatment by filtering the patient’s blood through a specialized filter.
- Acute Peritoneal Dialysis: As the most widely used and available form of dialysis used in children, Acute Peritoneal Dialysis supports kidney function by maintaining fluid and electrolyte balance daily for anywhere between eight to 24 hours. This is done by using a patient’s own peritoneal membrane as a filter in association with a PD catheter. This form of dialysis is often used after cardiopulmonary bypass as it provides a safe and temporary dialysis option.
- Continuous Renal Replacement Therapy (CRRT): Commonly used in the Pediatric Intensive Care Units, CRRT is a continuous form of dialysis that supports kidney function by maintaining a fluid and electrolyte balance 24/7. CRRT is reserved for the sickest patients with acute kidney injury as it supports the chance of regaining kidney function and renal function recovery.
- Aquapheresis or Ultrafiltration: A medical therapy that supports kidney function by removing excess fluid from the patient in a slow manner that helps restore a patient’s fluid balance. Fluid removal using the Aquapheresis technique is done gradually and has no significant impact on a patient’s blood pressure, heart rate of electrolytes. This procedure is usually performed for four to six hours on patients who are fluid overloaded due to surgical procedures, heart failure or kidney disease.
Acute Therapeutic Pheresis:
Pheresis is a therapy that is used to remove antibodies pathogenic proteins or unwanted cellular components from a patient. It is commonly used for patients who may be experiencing acute rejection of a transplanted organ, some neurological issues and those patients with extremely elevated white cell counts or elevated sickle hemoglobin cells.
- Acute Therapeutic Plasma Exchange (Plasmapheresis): A therapy used to remove circulating pathogenic proteins or antibodies which are elevated due to a response to an autoimmune disease. These antibodies and proteins are found in the blood, more specifically, the plasma. Plasmapheresis provides a way to remove plasma and discard the unwanted antibodies and proteins.
- Acute Red Blood Cell Exchange (Erythrocytapheresis): Removes abnormal red cells from a patient that are causing symptoms, such as stroke, iron overload, or organ dysfunction. Commonly used for sickle cell patients in acute sickling crisis, or used as preventive maintenance to avoid complications of the disease.
- Acute White Blood Cell Depletion (Leukapheresis): This therapy removes white blood cells from a patient with newly diagnosed or relapsing leukemia. By removing the high level of white blood cells from the blood, the chemotherapy therapy used to treat the leukemia can be more effective.
Acute Extracorporeal Liver Support: Cincinnati Children’s is excited to be one of the few sites worldwide that is able to offer acute extracorporeal liver support, or MARS therapy, for those patients that have hepatic encephalopathy or for the treatment of drug overdose and poisonings.
- MARS: Molecular Adsorbent Recirculating System provides efficient removal of exogenous and endogenous hepatic toxins in patients with acute liver failure. This therapy supports the patient with acute liver failure, providing a chance to recover native liver function.